Ciprofloxacin resistance by altered gyrase and drug efflux system inPseudomonas aeruginosa (original) (raw)

Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO

jaym ez epiayu epiayu

Antimicrobial Agents and Chemotherapy, 1988

View PDFchevron_right

The Role of DNA Gyrase (gyrA) in Ciprofloxacin-Resistant Locally Isolates Pseudomonas aeruginosa in Al-Khadhmiya Teaching Hospital Baghdad, Iraq

Jabbar S Hassan

Journal of Pure and Applied Microbiology

View PDFchevron_right

Detection of DNA Gyrase Mutation and Multidrug Efflux Pumps Hyperactivity in Ciprofloxacin Resistant Clinical Isolates of Pseudomonas aeruginosa

JoMMID Journal

Journal of Medical Microbiology and Infectious Diseases, 2013

View PDFchevron_right

Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem

Joaquim Trias

Antimicrobial Agents and Chemotherapy, 1995

View PDFchevron_right

Efflux-mediated ciprofloxacin and cefixime resistance in Pseudomonas aeruginosa

Sajeeb Khan

Environmental and Experimental Biology

View PDFchevron_right

In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa

Naeem Akhtar

Pakistan journal of pharmaceutical sciences, 2013

View PDFchevron_right

The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins

Martha Clark

2010

View PDFchevron_right

ANALYSES of parC and gyrA MUTATIONS in CIPROFLOXACIN-RESISTANT and SUSCEPTIBLE Pseudomonas aeruginosa ISOLATED FROM SOIL by PCR-RFLP and SSCP METHOD

Sumer Aras

2016

View PDFchevron_right

Real-time PCR detection of Pseudomonas aeruginosa in clinical and municipal wastewater and genotyping of the ciprofloxacin-resistant isolates

Silke Kirchen, Thomas Schwartz

FEMS Microbiology Ecology, 2000

View PDFchevron_right

Minimum Inhibitory Concentration of Ciprofloxacin against Pseudomonas Aeruginosa in the Presence of the Efflux Inhibitor Phenylalanine-arginine Beta-naphthylamide

Internal Medcine and Medical Investigation Journal

View PDFchevron_right

Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa

Xilin Zhao

International Journal of Antimicrobial Agents, 2006

View PDFchevron_right

Role of the MexEF-OprN Efflux System in Low-Level Resistance of Pseudomonas aeruginosa to Ciprofloxacin

C. Llanes

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

In Vitro Synergy of Ciprofloxacin and Gatifloxacin against Ciprofloxacin-Resistant Pseudomonas aeruginosa

George Pankey

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

Effect of Ciprofloxacin Concentration on the Frequency and Nature of Resistant Mutants Selected from Pseudomonas aeruginosa mutS and mutT Hypermutators

Carlos Argarana

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

Comparative Genome Analysis of Ciprofloxacin-Resistant Pseudomonas aeruginosa Reveals Genes Within Newly Identified High Variability Regions Associated With Drug Resistance Development

Morgan Giddings

Microbial Drug Resistance, 2013

View PDFchevron_right

Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin

Leonidas Tzouvelekis

Antimicrobial Agents and Chemotherapy, 1989

View PDFchevron_right

In Vitro Synergy of Ciprofloxacin and Gatifloxacin against Ciprofloxacin-Resistant Pseudomonas aeruginosa

George Pankey

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

Ciprofloxacin or Imipenem Use Correlates with Resistance in Pseudomonas aeruginosa

A. Kabani

Canadian Journal of Infectious Diseases, 1998

View PDFchevron_right

Quantitative Contributions of Target Alteration and Decreased Drug Accumulation to Pseudomonas aeruginosa Fluoroquinolone Resistance

Andreas Dötsch

Antimicrobial Agents and Chemotherapy, 2013

View PDFchevron_right

In vitro synergism of -lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa

Irene Galani

View PDFchevron_right

Evaluation of Fluoroquinolone Resistance and Its Role in the Emergence of Multidrug Resistant Phenotypes in Pseudomonas aeruginosa

ROUCHELLE TELLIS

2014

View PDFchevron_right

Involvement of Mutation in Serine 83 of Quinolone Resistance-Determining Region of gyrA Gene in Resistance to Ciprofloxacin in Escherichia Coli

samira zolfaghari

2019

View PDFchevron_right

Carbapenem and Fluoroquinolone Resistance in Multidrug Resistant Pseudomonas aeruginosa Isolates from Al-Zahra Hospital, Isfahan, Iran

JoMMID Journal

Journal of Medical Microbiology and Infectious Diseases, 2014

View PDFchevron_right

Pseudomonas aeruginosa deficient in 8-oxodeoxyguanine repair system shows a high frequency of resistance to ciprofloxacin

Carlos Argarana

FEMS Microbiology Letters, 2008

View PDFchevron_right

Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa

Jan Verhoef

International Journal of Antimicrobial Agents, 2003

View PDFchevron_right

Topoisomerases II Mutations in Ciprofloxacin-resistant Clinical Isolates of Pseudomonas aeruginosa in Makassar, Indonesia

Prof. Mochammad Hatta, MD, PhD, Clin Microbiologist (Cons)

View PDFchevron_right

Structural Changes and Differentially Expressed Genes in Pseudomonas aeruginosa Exposed to Meropenem-Ciprofloxacin Combination

Katiany Caleffi-ferracioli, Marcia Fernandez, Rosilene Cardoso

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs

Jordi Vila

1994

View PDFchevron_right

An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa

Hassan Almoazen

2007

View PDFchevron_right